content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0000107476</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
        <contact>
          <contactName>Regina White</contactName>
          <contactPhoneNumber>801-532-1313</contactPhoneNumber>
          <contactEmailAddress>rwhite@wdco.com</contactEmailAddress>
        </contact>
        <flags>
          <overrideInternetFlag>false</overrideInternetFlag>
        </flags>
        <notifications>
          <notificationEmailAddress>rwhite@wdco.com</notificationEmailAddress>
        </notifications>
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001514946</issuerCik>
        <issuerName>AXIM BIOTECHNOLOGIES, INC.</issuerName>
        <secFileNumber>000-54296</secFileNumber>
        <issuerAddress>
          <com:street1>6191 CORNERSTONE COURT, E</com:street1>
          <com:street2>SUITE 114</com:street2>
          <com:city>SAN DIEGO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>92121</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>(212) 751-0001</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>WILSON-DAVIS &amp; CO., INC.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Director</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Wilson Davis</name>
          <address>
            <com:street1>236 So. Main Street</com:street1>
            <com:city>Salt Lake City</com:city>
            <com:stateOrCountry>UT</com:stateOrCountry>
            <com:zipCode>84101</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>845012</noOfUnitsSold>
        <aggregateMarketValue>76051.00</aggregateMarketValue>
        <noOfUnitsOutstanding>164915277</noOfUnitsOutstanding>
        <approxSaleDate>09/15/2022</approxSaleDate>
        <securitiesExchangeName>N/A</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>08/23/2022</acquiredDate>
        <natureOfAcquisitionTransaction>Debt Conversion</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Acquired from Issurer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>845012</amountOfSecuritiesAcquired>
        <paymentDate>02/10/2022</paymentDate>
        <natureOfPayment>Debt Conversion</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <remarks>1. The 845,012 shares were acquired via the conversion of a $25,000 note plus interest thereon.  The convertible note was acquired on February 10, 2022, with full cash payment of $25,000.</remarks>
      <noticeSignature>
        <noticeDate>10/06/2022</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>09/21/2022</planAdoptionDate>
        </planAdoptionDates>
        <signature>Blake N Schroeder</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3530}]
text: 144
  0000107476
  XXXXXXXX
  LIVE
  Regina White
  801-532-1313
  rwhite@wdco.com
  false
  rwhite@wdco.com
  0001514946
  AXIM BIOTECHNOLOGIES, INC.
  000-54296
  6191 CORNERSTONE COURT, E
  SUITE 114
  SAN DIEGO
  CA
  92121
  (212) 751-0001
  WILSON-DAVIS & CO., INC.
  Director
  Common
  Wilson Davis
  236 So. Main Street
  Salt Lake City
  UT
  84101
  845012
  76051.00
  164915277
  09/15/2022
  N/A
  Common
  08/23/2022
  Debt Conversion
  Acquired from Issurer
  N
  845012
  02/10/2022
  Debt Conversion
  Y
  1. The 845,012 shares were acquired via the conversion of a $25,000 note plus interest thereon.  The convertible note was acquired on February 10, 2022, with full cash payment of $25,000.
  10/06/2022
  09/21/2022
  Blake N Schroeder